GlobeNewswire by notified

Norsk Hydro: Third quarter 2020 - Strong cash generation, improving markets

Share

Hydro’s underlying EBIT for the third quarter of 2020 was NOK 1,407 million, up from NOK 1,366 million in the same quarter last year. Extruded Solutions saw improving volumes from the previous quarter and a favorable cost position. The extended maintenance at the Paragominas bauxite pipeline in Brazil is finalized, and the Alunorte alumina refinery is ramping up production

  • Underlying EBIT NOK 1,407 million
  • Strong cash generation
  • Markets continue recovery from Q2 lows
  • Extruded Solutions uEBITDA up 28% vs Q3 2019
  • Paragominas maintenance finalized, Alunorte ramping up to nameplate capacity
  • RSK value secured through Hydro-Lyse transaction
  • Positive developments in EU regulatory framework


“Our top priority is the health and safety of our people and the communities where we operate. Hydro’s organization is maneuvering the Covid-19 situation, protecting people and operations while generating cash. I am pleased to see strong cash generation as a result of our efforts. At the same time, we are pursuing our profitability and sustainability agenda, strengthening our low-carbon position and exploring new growth areas,” says President and CEO Hilde Merete Aasheim.

Extruded Solutions experienced a faster-than-expected recovery, especially in Europe, a favorable cost position and insurance compensation of NOK 192 million related to the cyber-attack in 2019. Reduced raw material costs, improved fixed costs and positive currency effects, as both the NOK and BRL weakened against the USD and EUR, all contributed positively to the third quarter result. The positive elements were offset by a lower result from Bauxite & Alumina, due to the Paragominas maintenance and reduced realized alumina and aluminium prices.

On August 18, Hydro halted operation of the pipeline transporting bauxite from Paragominas to Alunorte for extended maintenance to replace a section of the pipeline earlier than planned, temporarily halting production at Paragominas and reducing production at Alunorte to 50 percent of full capacity. On October 8, Paragominas resumed production. Alunorte is now ramping up production towards nameplate capacity.

“I am happy to see Alunorte back on track and ramping up production. We have also decided to resume full production at our Husnes plant in Norway by end of November, after running at half capacity since the financial crisis in 2009. Husnes is among the most climate-efficient aluminium plants in the world, producing a material acknowledged by the European Union as an essential building block for the low-carbon, circular society,” says Aasheim.

Global GDP and industrial production have recovered during the quarter, but the Covid-19 situation continues to cause market uncertainty. The global fall in demand and government-imposed restrictions have negatively affected operations during the quarter. The Covid-19 situation has mostly affected Extruded Solutions and Rolled Products, although order intake and capacity utilization have improved. Bauxite & Alumina, Primary Metal, Metal Markets recycling facilities and Energy have been operating largely as normal during the quarter.

Hydro’s improvement efforts are moving forward with full speed, focusing on the cost levers we can control in these uncertain times. The target NOK 4.1 billion by 2020 is behind plan due to the pipeline maintenance. However, the overall 2023 goal of NOK 7.3 billion in improvements remains.

The EU's revised guidelines for CO2 compensation pave the way for continued production of low-carbon aluminum in Norway. For Hydro's renewable energy-based aluminum production, predictable and robust compensation of the actual CO2 surcharge in power prices will make a critical contribution to our operations. “Low-carbon aluminium products can play a crucial role in reducing global CO2 emissions, meeting the growing demand for these products in a number of sectors, including transport and construction,” says Aasheim.

In addition, The European Commission announced on September 22, 2020, its decision to impose provisional antidumping duties on aluminium extrusions originating in China. The duties are an outcome of an investigation opened in February 2020. The European Commission has now found that Chinese extrusions have been sold in the European Union at prices so low that they can be considered dumping and unfair competition to EU producers.

For Hydro’s around 40 extrusion plants in Europe, the antidumping action is a move that will mitigate unfair competition. For Hydro’s customers, this will contribute to making sure Europe continues to have a viable extrusion industry which will still face strong competition due to the many players in the market.

Hydro's net debt position decreased from NOK 13.2 billion to NOK 9.9 billion at the end of the quarter. Net cash provided by operating activities amounted to NOK 4.5 billion. Net cash used in investment activities, excluding short term investments, amounted to NOK 1.5 billion.

Hydro held NOK 17.5 billion in cash and cash equivalents and NOK 4.2 billion short-term deposits, included in short-term investments, at the end of the third quarter. The revolving credit facility of USD 1.6 billion was fully available at the end of the quarter.

Investor contact:

Line Haugetraa,
Head of Investor Relations,
+47 41406376
line.haugetraa@hydro.com

Press contact:

Halvor Molland,
Senior vice president, Media Relations
+47 92979797
Halvor.molland@hydro.com

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Attachments

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)19.4.2024 12:10:00 CEST | Press release

Alvotech, in agreement with Teva Pharmaceuticals, has signed an agreement with a strategic partner to bring to the U.S. market the newly FDA approved high-concentration interchangeable biosimilar to Humira®The agreement broadens patient access and further commitment to availability of vital biologics in the U.S. and globally Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today a long-term agreement with a strategic partner to further enhance access to Adalimumab-ryvk in the U.S. market, the newly U.S. Food and Drug Administration (FDA) approved high-concentration interchangeable biosimilar to Humira. “This new partnership agreement supports our financial guidance and reflects Alvotech’s strong commitment to increasing patient access to more affordable healthcare,” said Robert Wessman, Chairman and CEO of Alvotech. The current multi-product commercialization partnership between T

Vaccinologists Keith Klugman and Shabir Madhi Awarded Sabin’s Prestigious Gold Medal; Infectious Diseases Epidemiologist Nicole Basta Receives Rising Star Award19.4.2024 12:00:00 CEST | Press release

WASHINGTON, April 19, 2024 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute yesterday presented the Albert B. Sabin Gold Medal to physician-researchers Keith Paul Klugman and Shabir Ahmed Madhi, and its Rising Star award to infectious diseases epidemiologist Nicole Elaine Basta at a ceremony in the National Academy of Sciences building in Washington D.C. Klugman and Madhi received the Sabin Gold Medal, one of the highest recognitions for vaccinologists globally, for their seminal combined contributions to the development of vaccines against pneumonia and diarrheal disease – major causes of death in children in low- and middle-income countries (LMICs). Klugman first met his then-graduate student Madhi at South Africa’s University of the Witwatersrand (also known as Wits University), where Klugman established, and Madhi expanded, a now globally renowned infectious diseases research institute. Apart from pneumonia, their work focused on maternal and children’s vaccines including influenza,

Forløb af ordinær generalforsamling 202419.4.2024 11:59:58 CEST | pressemeddelelse

Investeringsforeningen Investin har i dag afholdt ordinær generalforsamling i henhold til tidligere offentliggjort dagsorden. Ledelsens beretning og årsrapporten for 2023, herunder de i januar 2024 udbetalte udlodninger samt bestyrelsens honorar for 2023 blev godkendt af generalforsamlingen. Alle de af bestyrelsen stillede forslag blev vedtaget, herunder overflytning af afdeling I&T Nordiske Aktier Large Cap og afdeling I&T Globale Aktier ESG Select samt vedtægtsændringer. Til bestyrelsen genvalgtes Kim Høibye, Jesper Lau Hansen, Henrik Vincents Johansen samt Tine Roed, og bestyrelsen konstituerede sig efterfølgende med Kim Høibye som formand. Som revisor for foreningen genvalgtes EY Godkendt Revisionspartnerselskab. Eventuelle henvendelser vedrørende denne meddelelse kan rettes til direktør Tage Fabrin-Brasted på tlf. 44 55 91 60. Med venlig hilsen Investeringsforeningen Investin Tage Fabrin-Brasted Direktør

Investeringsforeningen ValueInvest Danmark – Prospektopdatering19.4.2024 11:32:00 CEST | pressemeddelelse

Opdateret prospekt for Investeringsforeningen ValueInvest Danmark offentliggøres dags dato. Der er fore­taget følgende opdateringer i prospektet: Indsættelse af regnskabstal for 2023 Prospektet er vedhæftet denne fondsbørsmeddelelse og kan endvidere downloades på www.valueinvest.dk eller rekvireres ved henvendelse til BI Management A/S, Bredgade 40, 1260 København K, tlf. 77 30 90 00. Med venlig hilsen BI Management A/S Martin Fjordlund Smidt Direktør Vedhæftet fil Prospekt IF ValueInvest Danmark 2024.04.19 FINAL clean inkl. bilag

Forløb af ordinær generalforsamling i Investeringsforeningen ValueInvest Danmark den 19. april 202419.4.2024 11:30:00 CEST | pressemeddelelse

Bestyrelsens beretning Bestyrelsens beretning blev taget til efterretning. Årsrapport, udbytte og bestyrelsesmedlemmernes honorar Årsrapporten for 2023 blev enstemmigt godkendt, herunder bestyrelsens honorar samt forslag om udbetaling af udbytte på 13,60 kr. pr. bevis for andelsklasse A i ValueInvest Global KL, og udbytte på 14,60 kr. pr. bevis for andelsklasse W i ValueInvest Global KL. Udbyttebetalingen til investorerne er foretaget aconto den 5. februar 2024. Forslag fremsat af bestyrelsen Der blev ikke fremsat forslag under dette punkt. Valg til bestyrelsen Bestyrelsen havde indstillet til genvalg af Ole Steffensen, Jens Harck og Bent Erik Carlsen, der enstemmigt blev valgt som medlemmer af bestyrelsen. Valg af revisor EY Godkendt Revisionspartnerselskab blev genvalgt som revisor. Med venlig hilsen Bestyrelsen for Investeringsforeningen ValueInvest Danmark c/o BI Management A/S Bredgade 40 1260 København K

HiddenA line styled icon from Orion Icon Library.Eye